We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+19.94%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$9.37B
AUM Growth
+$1.16B
Cap. Flow
+$125M
Cap. Flow %
1.34%
Top 10 Hldgs %
19.5%
Holding
1,860
New
177
Increased
769
Reduced
722
Closed
101

Top Sells

Rank Stock Value
1
VET icon
Vermilion Energy
VET
+$20.6M
2
PL icon
Planet Labs
PL
+$17M
3
MRVL icon
Marvell Technology
MRVL
+$12.3M
4
ASTS icon
AST SpaceMobile
ASTS
+$10.5M
5
MSFT icon
Microsoft
MSFT
+$10.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 30.92%
2 Technology 22.36%
3 Industrials 9.58%
4 Financials 8.95%
5 Healthcare 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMRN icon
1526
BioMarin Pharmaceuticals
BMRN
$12.9B
$266K ﹤0.01%
+4,656
New +$255K
EWU icon
1527
iShares MSCI United Kingdom ETF
EWU
$3.81B
$266K ﹤0.01%
5,773
DXCM icon
1528
DexCom
DXCM
$33.2B
$266K ﹤0.01%
3,953
-2,040
-34% -$136K
GGME icon
1529
Invesco Next Gen Media and Gaming ETF
GGME
$45.6M
$266K ﹤0.01%
4,418
-112
-2% -$6.53K
ILOW
1530
AB International Low Volatility Equity ETF
ILOW
$1.88B
$265K ﹤0.01%
+5,822
New +$261K
PSTL
1531
Postal Realty Trust
PSTL
$717M
$265K ﹤0.01%
10,737
+370
+4% +$8.25K
MDGL icon
1532
Madrigal Pharmaceuticals
MDGL
$12.5B
$264K ﹤0.01%
492
ACGL icon
1533
Arch Capital
ACGL
$33.5B
$264K ﹤0.01%
2,715
-703
-21% -$66.3K
BHVN icon
1534
Biohaven
BHVN
$2.37B
$263K ﹤0.01%
17,679
-1,956
-10% -$21.1K
NTNX icon
1535
Nutanix
NTNX
$18.4B
$263K ﹤0.01%
5,162
-2,336
-31% -$106K
IFRA icon
1536
iShares US Infrastructure ETF
IFRA
$4.23B
$263K ﹤0.01%
4,172
-160
-4% -$9.76K
MOG.A icon
1537
Moog Inc Class A
MOG.A
$11.8B
$263K ﹤0.01%
+620
New +$212K
IBDR icon
1538
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
$3.27B
$262K ﹤0.01%
10,798
+282
+3% +$6.83K
FXN icon
1539
First Trust Energy AlphaDEX Fund
FXN
$403M
$261K ﹤0.01%
12,924
-51,758
-80% -$1.11M
TARS icon
1540
Tarsus Pharmaceuticals
TARS
$3.98B
$261K ﹤0.01%
4,150
DFUS
1541
Dimensional US Equity ETF
DFUS
$21.7B
$260K ﹤0.01%
3,176
-22
-0.7% -$1.74K
ZFEB
1542
Innovator Equity Defined Protection ETF - 1 Yr February
ZFEB
$152M
$260K ﹤0.01%
10,000
OMF icon
1543
OneMain Financial
OMF
$7.44B
$259K ﹤0.01%
4,245
+469
+12% +$26.4K
LEG
1544
DELISTED
Leggett & Platt
LEG
$259K ﹤0.01%
22,101
-2,600
-11% -$27.4K
GCC icon
1545
WisdomTree Enhanced Commodity Strategy Fund
GCC
$324M
$259K ﹤0.01%
11,414
+785
+7% +$19.3K
BA.PRA
1546
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$7.57B
$258K ﹤0.01%
3,833
-867
-18% -$61K
SPGM icon
1547
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.76B
$256K ﹤0.01%
+2,993
New +$250K
BAC.PRL icon
1548
Bank of America Series L
BAC.PRL
$4B
$256K ﹤0.01%
204
GHC icon
1549
Graham Holdings Company
GHC
$4.81B
$256K ﹤0.01%
224
+4
+2% +$4.5K
FRO icon
1550
Frontline
FRO
$10.3B
$255K ﹤0.01%
+7,335
New +$270K

Similar funds

Oppenheimer & Co's Q2 2026 Portfolio in Review

As of Q2 2026, Oppenheimer & Co held 1,860 positions worth $9.37B, up 14% from $8.21B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Oppenheimer & Co's Q2 2026 filing shows 177 new, 769 increased, 722 reduced and 101 closed positions. Its largest new stake was Vanguard US Momentum Factor ETF: 40,457 shares worth $10.1M. The largest sale was Vermilion Energy, an estimated $20.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

  • Oppenheimer & Co's largest Q2 2026 buy was Vanguard US Momentum Factor ETF: 40,457 shares worth $10.1M.
  • Oppenheimer & Co added most to Eaton Vance Total Return Bond ETF in Q2 2026, an estimated $8.85M increase.
  • Oppenheimer & Co's biggest Q2 2026 reduction was Vermilion Energy, cutting an estimated $20.6M.
  • Oppenheimer & Co fully exited Invesco CurrencyShares Swiss Franc Trust in Q2 2026, selling an estimated $3.47M.
  • Oppenheimer & Co's ten largest holdings make up 19% of its $9.37B portfolio in Q2 2026.
  • Oppenheimer & Co opened 177 new positions and closed 101 in Q2 2026.
  • Oppenheimer & Co's portfolio value rose 14% quarter-over-quarter to $9.37B.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.